lab webpage > lab members > Lana Dépatie
Lana Dépatie
Department of Psychology
McGill University
Stewart Biological Sciences Building
1205 Dr Penfield Ave
Montreal, Qc, Canada
H3A 1B1

Phone: (514) 398-4916
Fax: (514) 398-4896

Email: Lana at ego.psych.mcgill.ca
Note: Please replace at with @ for the above email address (written this way to prevent use by spammers).

I was born in Montréal, Québec, Canada. I went to Collège Édouard-Montpetit for CEGEP where I obtained a DEC in Social Sciences. Since then, I have been attending McGill University where I graduated in 1998 with a B.A. in Psychology. Subsequently, I began graduate studies in the Department of Psychiatry. My Master's project was an investigation of the effect of nicotine on different attentional and oculomotor functions in schizophrenia under the supervision of Dr. Samarthji Lal and Dr. Gillian O'Driscoll. I graduated with an M.Sc. in the fall 2001, then worked for one year in the laboratory of Dr. Ridha Joober investigating the genetic basis of schizophrenia. I am currently pursuing a Ph.D. in Clinical Psychology at McGill University under the supervision of Dr. Gillian O'Driscoll. I am investigating the pharmaco-genetics of Attention Deficit Hyperactivity Disorder (ADHD), as well as the genetics of risk markers for schizophrenia in collaboration with Dr. Joober.


Contents:

Awards and Honours:

Lloyd Carr-Harris McGill Major Fellowship, 2004-2006.

Scottish Rite Charitable Foundation of Canada, Doctoral Research Award, 2004-2006.

Douglas Hospital Research Centre, Neuroscience Research Day, Student Presentation Award, 2003.

McGill University, Alma Mater Travel Award, 2003.

Douglas Hospital Research Center, N.P.V. Nair Award, 2002.

FRSQ-FCAR-Santé Doctoral Award 2002-2004
Fonds de la Recherche en Santé du Québec

Graduated M.Sc, Dean's Honour Roll, 2001.

Society for Psychophysiological Research, Tursky Award, Best Student Presentation, 2001.

McGill Major Fellowship (award for women in Medicine), 2001.

Canadian College of Neuropsychopharmacology (CCNP) Student Travel Bursary to present research at the CCNP Annual Meeting in Banff, Alberta, 2001.

Alma Mater Student Research Travel Grant, McGill University 2001.

top

Research Interests:

My principal research interests are in the areas of neuroscience and psychopathology, focusing on schizophrenia and ADHD. I am presently conducting a study on the genetic basis of ADHD. My research will provide information about the genetics of ADHD and genes involved in the response to Ritalin (methylphenidate), the major treatment for ADHD.

top

Areas of Interest:
  • Schizophrenia
  • Behavioral markers of risk for schizophrenia
  • ADHD
  • Cognitive function (attention, eye movements)
  • Brain imaging
  • Genetics
  • Pharmacology and cognition
  • Nicotine
  • Apomorphine
top

Selected Publications:

O'Driscoll GA, Dépatie L, Holahan AL, Savion-Lemieux T, Barr RG, Jolicoeur C, Douglas VI. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder. Biological Psychiatry. 2005 Jun 1;57(11):1452-60.

Dépatie L & Lal S. Apomorphine and the dopamine hypothesis of schizophrenia: A dilemma? Journal of Psychiatry and Neuroscience, 26(3), 2001: 203-220. (download .pdf - 112 KB)

Dépatie L, O'Driscoll, GA, Wolff ALV, Atkinson V, Thavundayil JX, Ng Ying Kin N & Lal S. Nicotine and behavioral markers of risk for schizophrenia: A double-blind, placebo-controlled, crossover study. Neuropsychopharmacology, 2002, 27(6), 1056-1070. (view paper)

top

Published Abstracts and Conference Proceedings:

Dépatie L,Holahan A-LV, Douglas VI, Savion-Lemieux T, O'Driscoll GA. Executive functions in Attention Deficit Hyperactivity Disorder. Brenda Milner Symposium, Montreal Neurological Institute, September 22, 2003. Montreal, QC, Canada.

Dépatie L, Holahan A-LV, Douglas VI, Savion-Lemieux T, O'Driscoll GA. Executive functions in Attention Deficit Hyperactivity Disorder. Canadian College of Neuropsychopharmacology, June 1-4, 2003. Montreal, QC, Canada.

Dépatie L, Holahan A-LV, Douglas VI, Savion-Lemieux T, O'Driscoll GA. Inhibition and response selection in attention deficit hyperactivity disorder. Society for Neural Control of Movement, April 22-27, 2003. Santa Barbara, CA, USA.

Dépatie L, Holahan A-LV, Douglas VI, Savion-Lemieux T, O'Driscoll GA. Inhibition and response selection in attention deficit hyperactivity disorder. Douglas Hospital Neuroscience Research Day, March 24, 2003. Verdun, QC, Canada.

Dépatie L, O'Driscoll GA, Holahan A-LV, Thavundayil J, Ng Ying Kin N, Lal S. Modulation of behavioural markers of risk for schizophrenia by nicotine. International Journal of Psychophysiology, 2002, 54, 52.

Dépatie L, O'Driscoll GA, Wolff ALV, Atkinson V, Thavundayil J, Ng Ying Kin N, Lal S. Nicotine improves attention and eye movement performance in schizophrenia. Psychophysiology, 2001, 38(Suppl 1): S36. (view Power Point presentation)

Dépatie L, O'Driscoll GA, Wolff ALV, Atkinson V, Thavundayil JX, Ng Ying Kin N & Lal S. Nicotine improves behavioral risk markers for schizophrenia. Canadian College of Neuropsychopharmacology. June 17 -20, 2001. Banff, Ab., Canada.

Dépatie L, O'Driscoll GA, Wolff ALV, Atkinson V, Thavundayil JX, Ng Ying Kin N & Lal S. Effect of nicotine on attention and oculomotor tasks in schizophrenia. International Congress on Schizophrenia Research. April 27 - May 3, 2001. Whistler, BC, Canada.

Dépatie L, O'Driscoll GA, Wolff AVG, Atkinson V, Thavundayil JX, Ng Ying Kin N & Lal S. Effect of nicotine on attention and oculomotor tasks in schizophrenia. Schizophrenia Research, 2001; 49, 213.

O'Driscoll GA, Wolff ALV, Atkinson V, Affifi T, Dépatie L & Lal S. Nicotine and behavioral markers of risk: A double-blind, placebo-controlled, crossover study. International Congress on Schizophrenia Research. April 16-20, 1999. Santa Fe, NM, USA.

O'Driscoll GA, Wolff AVG, Atkinson V, Affifi T, Dépatie L & Lal S. Nicotine and behavioral markers of risk: A double-blind, placebo-controlled, crossover study. Schizophrenia Research, 1999; 36, 312.

top
lab webpage | lab members

Webmaster: Josie Caro
August 5, 2005